Objective: To identify the magnitude and possible predictors of contralateral lobe involvement and contralateral extraprostatic extension (EPE) in prostatic biopsy—defined localized unilateral cancers. Patients and Methods: Between January 2005 and August 2009, 1861 patients underwent robotic-assisted radical prostatectomy at the authors’ institution. A total of 1114 had unilateral disease on preoperative biopsy. Final histopathology reports of these patients were reviewed. Results: Of the 1114 patients with unilateral disease on biopsy, 867 (77.9%) had contralateral or bilateral disease on final histopathology. EPE was found in 132 patients (11.9%). Twenty patients (1.8%) had contralateral EPE involvement. High-grade prostatic intraepithelial neoplasm (HGPIN) on biopsy was the significant predictor of contralateral lobe involvement on both univariate (P = .02; odds ratio [OR] = 1.791) and multivariate analysis (P = .004; OR = 2.677). Clinical stage T2 was the significant predictor of contralateral EPE on both univariate (P = .012; OR = 5.250) and multivariate analysis (P = .007; OR = 8.656). Conclusion: HGPIN on biopsy significantly predicts for contralateral lobe involvement and should be considered an exclusion criterion for focal therapy in prostate cancer patients. Patients with palpable tumor on digital rectal examination should be advised in favor of radical treatment as these patients may harbor more aggressive tumors involving the contralateral side despite the biopsy findings.
Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2.
SEER Cancer Statistics Review 1975-2006. http://seer.cancer.gov/statfacts/html/prost.html?statfacts_page=prost.html&x=13&y=16 . Retrieved July 26, 2010.
3.
Smither AR, Guralnick ML, Davis NB, See WAQuantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. BMC Urol. 2007 :7:2.
4.
Mettlin CJ, Murphy GP, Sylvester J., McKee RF, Morrow M., Winchester DPResults of hospital cancer registry surveys by the American College of Surgeons: outcomes of prostate cancer treatment by radical prostatectomy. Cancer. 1997;80: 1875-1881.
5.
Jayram G., Eggener SEPatient selection for focal therapy of localized prostate cancer. Curr Opin Urol. 2009;19:268-273.
6.
Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy . Cancer. 2009;115:2104-2110.
7.
Fukagai T., Namiki T., Namiki H., Carlile RG, Shimada M., Yoshida H.Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens. Pathol Int. 2001; 51:364-370.
8.
Altay B., Kefi A., Nazli O., Killi R., Semerci B., Akar I.Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens. Urol Int. 2001;67: 14-18.
9.
Montesino Semper M., Jimenez Aristu J., Reparaz Romero B., et al. Correlation between Gleason score on prostate biopsies diagnostic of adenocarcinoma and radical prostatectomy specimens [in Spanish]. Arch Esp Urol. 2004;57:519-523.
10.
Arellano L. , Castillo O., Metrebian E.Concordance of Gleason histological scoring for prostatic cancer in needle biopsies and the surgical piece obtained during radical prostatectomy [in Spanish]. Rev Med Chil. 2004;132:971-978.
11.
Cookson MS, Fleshner NE, Soloway SM, Fair WRCorrelation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol. 1997;157:559-562.
12.
Moore R.The morphology of small prostatic cancenomas. J Urol. 1935;33:224.
13.
Greene DR, Rogers E., Wessels EC, et al. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features. J Urol. 1994;151:1301-1307.
14.
Wise AM, Stamey TA, McNeal JE, Clayton JLMorphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology. 2002;60: 264-269.
15.
Li TY, Lu XM, Su SW, et al. Detection of EBV-DNA, EBNA2 and LMP-1 in tumor tissues of han and uygur patients with nasopharyngeal carcinoma in Xinjiang [in Chinese] . Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2000 ;14:76-77.
16.
Meiers I., Waters DJ, Bostwick DGPreoperative prediction of multifocal prostate cancer and application of focal therapy: review2007. Urology. 2007;70:3-8.
17.
Mouraviev V., Mayes JM, Sun L., Madden JF, Moul JW, Polascik TJProstate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer . 2007;110:906-910.
18.
Frota R., Stein RJ, Turna B., et al. Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins? BJU Int . 2009;104:1599-1603.
19.
Yoon GS, Wang W., Osunkoya AO, Lane Z., Partin AW, Epstein JIResidual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol. 2008; 179:2203-2206.
20.
Qian J., Wollan P., Bostwick DGThe extent and multicentricity of high-grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol . 1997;28:143-148.
21.
Tewari A., Horninger W., Badani KK, et al. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int. 2005;96:29-33.
22.
Pierorazio PM, Lambert SM, Matsukhani M., et al. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy . BJU Int. 2007;100:1066-1070.
23.
Durkan GC, Sheikh N., Johnson P., Hildreth AJ, Greene DRImproving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int. 2002;89:33-39.
